The Taiwan Government’s 2024 Biotechnology Industry Strategy Advisory Committee outlined key areas for advancing the biotech sector, including AI-driven innovation, medical data integration, precision health, and market expansion. AI plays a pivotal role in improving drug development, disease detection, and smart health management. The government is focusing on integrating digital health platforms to enhance service efficiency while balancing data privacy concerns.
The strategy emphasizes cultivating talent, attracting funding, and fostering public-private partnerships to drive industry growth. By leveraging digital technologies and international collaboration, the government aims to enhance Taiwan’s global competitiveness and commercialize smart healthcare innovations effectively.
